Back to search
FDAFDA · Food and drugs·Recall number D-0215-2020

S-E2/TEST CYP 0.4MG/1MG/MLMDV IN OIL INJECTION, 10 ml glass vial, Rx Only, Red Mountain Compounding Rx.

Published November 13, 2019 · Recall initiated: August 12, 2019

Summary

FDA records drug Class II recall D-0215-2020, published November 13, 2019 and initiated August 12, 2019. Recalling firm: First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy; Status: Terminated; Reported quantity: 1x10 glass vials; Lot: Lot #: S06262019DT@08, Exp 9/26/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
Distributor
Nationwide in the USA
Lot
Lot #: S06262019DT@08, Exp 9/26/19;
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was S-E2/TEST CYP 0.4MG/1MG/MLMDV IN OIL INJECTION, 10 ml glass vial, Rx Only, Red Mountain Compounding Rx. recalled?

Yes. FDA published recall D-0215-2020 on November 13, 2019. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter